CVS Health Corporation
HealthcareNYSE:CVS · New York Stock Exchange
+$1.30 today
Vol 6.13M · Avg 7.98M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
2.4%
avg 9.3%
ROIC
4.7%
avg 5.6%
ROA
0.7%
avg 3.2%
Analysis
ROIC is currently the strongest return metric at 4.7% versus its period average of 5.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
J. David Joyner CEBS | CEO, President & Chairman | $6.65M | — | 61 | $129,316.00 | 0.01% |
Prem S. Shah | Executive Vice President & Group President | $4.38M | — | 46 | $33,421.00 | <0.01% |
Steven Hale Nelson | Executive Vice President & President of Aetna | $4.34M | — | 67 | $2,900.00 | <0.01% |
Tilak Mandadi | EVice President of Ventures and Chief Experience & Technology Officer | $3.98M | — | 62 | $10,133.00 | <0.01% |
Samrat S. Khichi | Executive Vice President, Corporate Services & Chief Legal Officer | $3.39M | — | 59 | $33,421.00 | <0.01% |
Brian O. Newman | Executive Vice President & Chief Financial Officer | $2.82M | — | 57 | $3,008.00 | <0.01% |
Heidi Capozzi | Executive Vice President & Chief People Officer | $1.85M | — | 56 | $13,023.00 | <0.01% |
Roger N. Farah | Executive Director | $76,250.00 | — | 73 | $19,438.45 | <0.01% |
David A. Falkowski | Executive Vice President & Chief Compliance Officer | — | — | — | $18,355.04 | <0.01% |
Gustavo A. Giraldo | Head of Markets of Healthcare Benefits | — | — | 53 | $18,355.04 | <0.01% |
James David Clark | Senior Vice President, Controller & Chief Accounting Officer | — | — | 61 | $129,316.00 | 0.01% |
Tracy Louise Smith | Senior VP & Treasurer | — | — | — | — | — |
Kristina V. Fink | Senior VP, Chief Governance Officer & Corporate Secretary | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
10
$346.27M
Net Sentiment
$346.27M
Net selling
Most Active
ROBBINS LARRY
8 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 10 sells worth $346.27M over the last 12 months. That adds up to net selling of $346.27M. ROBBINS LARRY was the most active insider with 8 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +15.2% | +6.6% (15yr)4 analysts |
| Revenue | N/A | N/A | +7.6% | +8.1% (15yr)7 analysts |
| Net Income | N/A | N/A | +10.7% | +7.5% (15yr)7 analysts |
| EBIT | N/A | N/A | +9.5% | +2.9% (15yr)7 analysts |
Analysis
Recent growth has been strongest in EPS at +15.2% over three years. Forward estimates point to Revenue at +8.1% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Bristol-Myers Squibb Company
NYSE:BMY
$116.66B
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
$112.57B
GSK plc
NYSE:GSK
$106.59B
Medtronic plc
NYSE:MDT
$103.09B
McKesson Corporation
NYSE:MCK
$94.82B
Elevance Health Inc.
NYSE:ELV
$87.26B
HCA Healthcare, Inc.
NYSE:HCA
$85.72B
Cigna Corporation
NYSE:CI
$78.84B
Cencora, Inc.
NYSE:COR
$54.67B
Humana Inc.
NYSE:HUM
$45.32B
Who manages CVS?
CVS Health Corporation (CVS) lists 13 active executives. The top listed executive is Prem S. Shah, Executive Vice President & Group President.
Are CVS insiders buying or selling?
Recent insider activity shows net selling of $157.68M.
Explore More
Continue the stock analysis
Jump to another research area for this company.